Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen A Harrison

Showing results (131-140 of 318) with videos related to

Pageof 32
Sort By:
Digestive Diseases and Sciences|March 24, 2025
Agile 3+ and 4 Scores Accurately Predict Major Adverse Liver Outcomes, Liver Transplant, Progression of MELD Score, the Development of Hepatocellular Carcinoma, and Death in NAFLDEmily Truong, Lynna Alnimer, Jeffrey A Gornbein, et al.
Journal of Hepatology|June 15, 2007
Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitisBogdan Balas, Renata Belfort, Stephen A Harrison, et al.
Plos One|February 2, 2024
Mapping crown rust resistance in the oat diploid accession PI 258731 (Avena strigosa)Rawnaq N Chowdhury, Tyler Gordon, Md Ali Babar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 19, 2007
Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypassSteven P Larson, Steven P Bowers, Nicole A Palekar, et al.
Hepatology (Baltimore, Md.)|July 13, 2011
Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trialDawn M Torres, Frances J Jones, Janet C Shaw, et al.
Therapeutic Advances in Gastroenterology|July 2, 2013
Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trialCarly Eckard, Renee Cole, Joshua Lockwood, et al.
Journal of Clinical Lipidology|May 6, 2014
An assessment by the Statin Liver Safety Task Force: 2014 updateHarold Bays, David E Cohen, Naga Chalasani, et al.
Alimentary Pharmacology & Therapeutics|July 23, 2019
Depression is associated with non-alcoholic fatty liver disease among adults in the United StatesDonghee Kim, Eric R Yoo, Andrew A Li, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 10, 2018
Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver diseaseDonghee Kim, Won Kim, Sae Kyung Joo, et al.
The Journal of Organic Chemistry|October 14, 2014
Synthesis of α-substituted vinylsulfonium salts and their application as annulation reagents in the formation of epoxide- and cyclopropane-fused heterocyclesJohnathan V Matlock, Sven P Fritz, Stephen A Harrison, et al.
Pageof 32

Showing results (131-140 of 318) with videos related to

Sort By:
Pageof 32
Digestive Diseases and Sciences|March 24, 2025
Agile 3+ and 4 Scores Accurately Predict Major Adverse Liver Outcomes, Liver Transplant, Progression of MELD Score, the Development of Hepatocellular Carcinoma, and Death in NAFLDEmily Truong, Lynna Alnimer, Jeffrey A Gornbein, et al.
Journal of Hepatology|June 15, 2007
Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitisBogdan Balas, Renata Belfort, Stephen A Harrison, et al.
Plos One|February 2, 2024
Mapping crown rust resistance in the oat diploid accession PI 258731 (Avena strigosa)Rawnaq N Chowdhury, Tyler Gordon, Md Ali Babar, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 19, 2007
Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypassSteven P Larson, Steven P Bowers, Nicole A Palekar, et al.
Hepatology (Baltimore, Md.)|July 13, 2011
Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trialDawn M Torres, Frances J Jones, Janet C Shaw, et al.
Therapeutic Advances in Gastroenterology|July 2, 2013
Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a randomized trialCarly Eckard, Renee Cole, Joshua Lockwood, et al.
Journal of Clinical Lipidology|May 6, 2014
An assessment by the Statin Liver Safety Task Force: 2014 updateHarold Bays, David E Cohen, Naga Chalasani, et al.
Alimentary Pharmacology & Therapeutics|July 23, 2019
Depression is associated with non-alcoholic fatty liver disease among adults in the United StatesDonghee Kim, Eric R Yoo, Andrew A Li, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 10, 2018
Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver diseaseDonghee Kim, Won Kim, Sae Kyung Joo, et al.
The Journal of Organic Chemistry|October 14, 2014
Synthesis of α-substituted vinylsulfonium salts and their application as annulation reagents in the formation of epoxide- and cyclopropane-fused heterocyclesJohnathan V Matlock, Sven P Fritz, Stephen A Harrison, et al.
Pageof 32